Brew, Bruce J.

Updated research nosology for HIV-associated neurocognitive disorders

Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology

HIV Research and TreatmentInfectious Diseases and Tuberculosis

Cited by 2,630

Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex

Maruff, P., Thomas, E., Cysique, L., Brew, B., Collie, A., Snyder, P., & Pietrzak, R. H. (2009) · Archives of Clinical Neuropsychology

Psychological Testing and AssessmentHistorical and Modern Theater Studies

Cited by 635

Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

Guillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 497

Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases

Lovelace, M. D., Varney, B., Sundaram, G., Lennon, M. J., Lim, C. K., Jacobs, K., Guillemin, G. J., & Brew, B. J. (2017) · Neuropharmacology

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 393

The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons

Rahman, A., Ting, K., Cullen, K. M., Braidy, N., Brew, B. J., & Guillemin, G. J. (2009) · PLoS ONE

Alzheimer's disease research and treatmentsTryptophan and brain disorders

Cited by 257

Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder:A consensus report of the mind exchange program

The Mind Exchange Working Group, Antinori, A., Arendt, G., Grant, I., Letendre, S., Chair, Munoz-Moreno, J. A., Eggers, C., Brew, B., Brouillette, M.-J., et al. (2013) · Clinical Infectious Diseases

HIV Research and TreatmentInfectious Diseases and Tuberculosis

Cited by 208

Effect of the Mediterranean diet on cognition and brain morphology and function: a systematic review of randomized controlled trials

Radd-Vagenas, S., Duffy, S. L., Naismith, S. L., Brew, B. J., Flood, V. M., & Fiatarone Singh, M. A. (2018) · The American Journal of Clinical Nutrition

Nutritional Studies and DietDementia and Cognitive Impairment Research

Cited by 176

Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease

Ting, K. K., Brew, B. J., & Guillemin, G. J. (2009) · Journal of Neuroinflammation

Neuroinflammation and Neurodegeneration MechanismsTryptophan and brain disorders

Cited by 166

Quinolinic Acid Production by Macrophages Stimulated with IFN-γ, TNF-α, and IFN-α

PEMBERTON, L. A., KERR, S. J., SMYTHE, G., & BREW, B. J. (1997) · Journal of Interferon & Cytokine Research

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 149

The kynurenine pathway and inflammation in amyotrophic lateral sclerosis

Chen, Y., Stankovic, R., Cullen, K. M., Meininger, V., Garner, B., Coggan, S., Grant, R., Brew, B. J., & Guillemin, G. J. (2010) · Neurotoxicity Research

Tryptophan and brain disordersAmyotrophic Lateral Sclerosis Research

Cited by 141

Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis

Guillemin, G. J., Smith, D. G., Kerr, S. J., Smythe, G. A., Kapoor, V., Armati, P. J., & Brew, B. J. (2000) · Redox Report

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 108

Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis

Guillemin, G. J., Meininger, V., & Brew, B. J. (2005) · Neurodegenerative Diseases

Tryptophan and brain disordersAmyotrophic Lateral Sclerosis Research

Cited by 105